ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,300,000 | -25.3% | 2,500,000 | -28.6% | 0.01% | -33.3% |
Q2 2023 | $1,739,150 | +23.9% | 3,500,000 | 0.0% | 0.01% | +28.6% |
Q1 2023 | $1,403,850 | -27.1% | 3,500,000 | 0.0% | 0.01% | -50.0% |
Q4 2022 | $1,925,000 | -2.3% | 3,500,000 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $1,971,000 | +1.7% | 3,500,000 | 0.0% | 0.01% | +33.3% |
Q2 2022 | $1,938,000 | +7.4% | 3,500,000 | 0.0% | 0.01% | +80.0% |
Q1 2022 | $1,805,000 | -2.2% | 3,500,000 | 0.0% | 0.01% | +66.7% |
Q4 2021 | $1,846,000 | – | 3,500,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 18,764 | $9,907,000 | 0.77% |
Pentwater Capital Management LP | 46,411,000 | $24,770,000 | 0.27% |
WHITEBOX ADVISORS LLC | 22,500,000 | $11,756,000 | 0.24% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $10,993,000 | 0.23% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,590,000 | $9,286,000 | 0.20% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $12,540,000 | 0.18% |
BlueCrest Capital Management Ltd | 7,000,000 | $3,705,000 | 0.12% |
DCF Advisers, LLC | 400,000 | $211,000 | 0.09% |
Walleye Capital LLC | 5,000 | $2,638,000 | 0.08% |
INGALLS & SNYDER LLC | 883,000 | $461,000 | 0.02% |